Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
Select a Condition
Age
Compensation
By participating in our study, you can help forward research on lung disease. Our researchers are hoping to learn more about the blood cells involved in the development of scarring lung diseases and create new treatment therapies.
Already approved for advanced non-small cell lung cancer, atezolizumab is a drug that may help those with early-stage lung cancer, as well. Participants in this clinical trial may take atezolizumab in conjunction with their chemotherapy treatments.
Help us look at how specific white blood cells are associated with hypersensitivity pneumonitis (HP) and impact how your disease affects you.
A new study is looking at an investigational drug that stimulates immune response to fight infection. If you have cystic fibrosis and an ongoing mycobacterial infection, this trial may be right for you.
Do you have mild to moderate osteoarthritis in your knee? Our researchers are conducting a study on an FDA-approved drug that may reduce osteoarthritis knee pain and improve function.
Help researchers predict which pulmonary diseases are predisposed to reflux. Our researchers are recruiting healthy individuals and people with pulmonary disease to undergo an esophageal stress test.
The purpose of this study is to learn more about lung disease found in contractors and U.S. military personnel serving in Iraq and Afghanistan after September 11, 2001.
This research study evaluates an investigational medication called Acthar® Gel (Acthar) as a potential treatment of pulmonary sarcoidosis.
National Jewish Health researchers are studying a new phosphate cream that could reduce painful inflammation. Children ages 2 to 17 with atopic dermatitis may qualify. Learn more.
The purpose of this research study is to identify the general and disease-specific sexual and reproductive health concerns of women with Cystic Fibrosis (CF).
Our researchers are trying to understand the connection, as well as how to prevent and treat lung disease in RA patients.
Our researchers are trying to understand how interstitial lung disease (ILD) develops in people with rheumatoid arthritis (RA), and how it may impact their quality of life.
The purposes of this study is to understand the relationship between chronic obstructive pulmonary disease (COPD) and high body mass index (BMI).
Do you have systemic sclerosis-associated pulmonary arterial hypertension (PAH)? Our researchers are trying to determine if a new medication, Tecfidera®, helps improve quality of life for patients with this disease.
The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).
Our researchers are studying the lungs of current and former smokers to understand how to improve the diagnosis and treatment of Chronic Obstructive Pulmonary Disease (COPD), a disease that is common among smokers. You do not need to have COPD to participate in this study.
People with systemic lupus erythematosus (SLE) may be able to improve brain function with Project EVO, an interactive digital technology currently in development with Akili Interactive. Learn more.
The purpose of this research study is to determine if an investigational medication can reduce inflammation, tissue scarring, and the number of pulmonary exacerbations, or episodes when breathing is more difficult, in people with cystic fibrosis (CF).
If you are an adult with sarcoidosis who is not on immunosuppressive therapy, you may be able to help our researchers learn more about different types of sarcoidosis and how it develops.
Does your mind race at night when you're trying to sleep? Our researchers are studying how people with insomnia and obstructive sleep apnea can benefit from cognitive behavioral therapy, a goal-oriented type of treatment that aims to identify and change inaccurate or negative thinking patterns...
Our researchers are studying lung diseases that develop from inhaling mineral dust over time. Although the cause of diseases such as "black lung" are known, it is not well understood why some people develop these diseases and others don't.
The purpose of this study is to determine how two medications, azithromycin and inhaled tobramycin, work when taken together to treat cystic fibrosis (CF) patients with chronic pseudomonas aeruginosa (PA) lung infections.
Are you one of the many people with atopic dermatitis (eczema) who continues to have dry, itchy skin, and repeat infections that are not controlled by your medicine? Our researchers are seeking participants for a clinical trial that will test a medication called dupilumab that was recently...
Our researchers are studying an investigational combination of medications, one used to treat asthma in adults and the other not yet approved to treat adult asthma, to determine if it can improve symptoms and lung function in asthma patients age 5 to 17.
Our researchers are studying an investigational medication to determine if it improves lung function in teens with asthma. By blocking a key receptor that causes inflammation in the lungs, the medication may improve and prevent symptoms such as wheezing and shortness of breath.
Is your asthma poorly controlled despite using inhalers? Our researchers are studying an investigational medicine that targets a substance known to play a role in causing asthma. You may be able to help them determine if this medication is effective in treating severe asthma.
Our researchers are studying glycerol phenylbutyrate (GPBA), also known as RAVICTI®, to determine how safe it is and how well people tolerate it in the treatment of cystic fibrosis (CF).
Do you have rheumatoid arthritis and interstitial lung disease (RA-ILD)? You may be able to help our researchers determine if people with RA-ILD can benefit from a medication called Pirfenidone, which has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic...
The purpose of this study is to test the effectiveness of a new investigational medication, PTI-801, in treating cystic fibrosis (CF).
Are you pregnant? Do you have a family history of allergic disease (asthma, eczema, environmental allergies, hay fever, etc.)? You may be able to help our researchers determine if your child and others are at risk of developing eczema and food allergies.
-
Gender: Any Gender
-
Ages: Parents 18-50, newborns 3-6 months
-
Compensation: Not Provided
-
Time Required: Four 1-hour visits over 6 months
Are you 18 or older with no history of chronic lung conditions? You may be able to help our researchers better understand lung disease. Compensation provided.
The purpose of this study is to learn more about how Opsumit® (the commercial form of the medication macitentan) is used in clinical practice to treat pulmonary arterial hypertension (PAH) and other conditions.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 1 year
Adults age 40 or older are needed to help our researchers determine if an investigational medication can help slow damage to the lungs in people who have COPD with emphysema.
/Image_3097-small.jpg.aspx?width=428&height=244&ext=.jpg)
The purpose of this study is to see if a drug called sirolimus slows development of lymphangioleiomyomatosis (LAM), a lung disease in which abnormal cells growing inside the lungs prevent them from working properly.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 2 years
The purpose of this study is to gather information about treatment of early-stage lung cancer in order to compare the effectiveness of surgery versus radiation therapy, potentially improving outcomes for patients with early-stage lung cancer.
The purpose of this clinical trial is to see if it better to receive an investigational medication or no further treatment after surgery (and possibly chemotherapy) to remove non-small cell lung cancer (NSCLC).
The purpose of this clinical trial is to study the safety and potential benefits of treating fibrotic hypersensitivity pneumonitis (FHP) with an investigational medication.
Do you have pulmonary hypertension (PH) related to lung disease? You may qualify for a clinical trial to help researchers determine the safety and effectiveness of an investigational medication.
Our researchers are looking for people with and without sarcoidosis for a clinical trial on genetic markers associated with the disease.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 1 visit
How does inflammation differ in psoriasis and atopic dermatitis (eczema) patients? Our researchers are trying to find out. If you or your child (age 12 or older) has a history of psoriasis, we need your help for a clinical trial.
-Study/Ezcema-Study.jpg.aspx?width=428&height=244&ext=.jpg)
If you or your child age 3 or older has atopic dermatitis (eczema), you may be able to help our researchers learn why some people with eczema have increased risk of skin infection.
.jpg.aspx?width=428&height=244&ext=.jpg)
Do you have eczema? If you are age 18 to 60, you may qualify for an NIH sponsored clinical trial to see if an investigational lotion is safe and if the lotion reduces or even eliminates, bacteria that cause skin infections. Compensation provided for qualified participants.
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.
Already approved for advanced non-small cell lung cancer, atezolizumab is a drug that may help those with early-stage lung cancer, as well. Participants in this clinical trial may take atezolizumab in conjunction with their chemotherapy treatments.
Help us look at how specific white blood cells are associated with hypersensitivity pneumonitis (HP) and impact how your disease affects you.
A new study is looking at an investigational drug that stimulates immune response to fight infection. If you have cystic fibrosis and an ongoing mycobacterial infection, this trial may be right for you.
Do you have mild to moderate osteoarthritis in your knee? Our researchers are conducting a study on an FDA-approved drug that may reduce osteoarthritis knee pain and improve function.
Help researchers predict which pulmonary diseases are predisposed to reflux. Our researchers are recruiting healthy individuals and people with pulmonary disease to undergo an esophageal stress test.
The purpose of this study is to learn more about lung disease found in contractors and U.S. military personnel serving in Iraq and Afghanistan after September 11, 2001.
This research study evaluates an investigational medication called Acthar® Gel (Acthar) as a potential treatment of pulmonary sarcoidosis.
The purpose of this research study is to identify the general and disease-specific sexual and reproductive health concerns of women with Cystic Fibrosis (CF).
Our researchers are trying to understand the connection, as well as how to prevent and treat lung disease in RA patients.
Our researchers are trying to understand how interstitial lung disease (ILD) develops in people with rheumatoid arthritis (RA), and how it may impact their quality of life.
The purposes of this study is to understand the relationship between chronic obstructive pulmonary disease (COPD) and high body mass index (BMI).
Do you have systemic sclerosis-associated pulmonary arterial hypertension (PAH)? Our researchers are trying to determine if a new medication, Tecfidera®, helps improve quality of life for patients with this disease.
The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).
Our researchers are studying the lungs of current and former smokers to understand how to improve the diagnosis and treatment of Chronic Obstructive Pulmonary Disease (COPD), a disease that is common among smokers. You do not need to have COPD to participate in this study.
People with systemic lupus erythematosus (SLE) may be able to improve brain function with Project EVO, an interactive digital technology currently in development with Akili Interactive. Learn more.
The purpose of this research study is to determine if an investigational medication can reduce inflammation, tissue scarring, and the number of pulmonary exacerbations, or episodes when breathing is more difficult, in people with cystic fibrosis (CF).
If you are an adult with sarcoidosis who is not on immunosuppressive therapy, you may be able to help our researchers learn more about different types of sarcoidosis and how it develops.
Does your mind race at night when you're trying to sleep? Our researchers are studying how people with insomnia and obstructive sleep apnea can benefit from cognitive behavioral therapy, a goal-oriented type of treatment that aims to identify and change inaccurate or negative thinking patterns...
Our researchers are studying lung diseases that develop from inhaling mineral dust over time. Although the cause of diseases such as "black lung" are known, it is not well understood why some people develop these diseases and others don't.
The purpose of this study is to determine how two medications, azithromycin and inhaled tobramycin, work when taken together to treat cystic fibrosis (CF) patients with chronic pseudomonas aeruginosa (PA) lung infections.
Are you one of the many people with atopic dermatitis (eczema) who continues to have dry, itchy skin, and repeat infections that are not controlled by your medicine? Our researchers are seeking participants for a clinical trial that will test a medication called dupilumab that was recently...
Is your asthma poorly controlled despite using inhalers? Our researchers are studying an investigational medicine that targets a substance known to play a role in causing asthma. You may be able to help them determine if this medication is effective in treating severe asthma.
Our researchers are studying glycerol phenylbutyrate (GPBA), also known as RAVICTI®, to determine how safe it is and how well people tolerate it in the treatment of cystic fibrosis (CF).
Do you have rheumatoid arthritis and interstitial lung disease (RA-ILD)? You may be able to help our researchers determine if people with RA-ILD can benefit from a medication called Pirfenidone, which has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic...
The purpose of this study is to test the effectiveness of a new investigational medication, PTI-801, in treating cystic fibrosis (CF).
Are you 18 or older with no history of chronic lung conditions? You may be able to help our researchers better understand lung disease. Compensation provided.
The purpose of this study is to learn more about how Opsumit® (the commercial form of the medication macitentan) is used in clinical practice to treat pulmonary arterial hypertension (PAH) and other conditions.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 1 year
Adults age 40 or older are needed to help our researchers determine if an investigational medication can help slow damage to the lungs in people who have COPD with emphysema.
The purpose of this study is to see if a drug called sirolimus slows development of lymphangioleiomyomatosis (LAM), a lung disease in which abnormal cells growing inside the lungs prevent them from working properly.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 2 years
The purpose of this study is to gather information about treatment of early-stage lung cancer in order to compare the effectiveness of surgery versus radiation therapy, potentially improving outcomes for patients with early-stage lung cancer.
The purpose of this clinical trial is to see if it better to receive an investigational medication or no further treatment after surgery (and possibly chemotherapy) to remove non-small cell lung cancer (NSCLC).
The purpose of this clinical trial is to study the safety and potential benefits of treating fibrotic hypersensitivity pneumonitis (FHP) with an investigational medication.
Do you have pulmonary hypertension (PH) related to lung disease? You may qualify for a clinical trial to help researchers determine the safety and effectiveness of an investigational medication.
Our researchers are looking for people with and without sarcoidosis for a clinical trial on genetic markers associated with the disease.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 1 visit
How does inflammation differ in psoriasis and atopic dermatitis (eczema) patients? Our researchers are trying to find out. If you or your child (age 12 or older) has a history of psoriasis, we need your help for a clinical trial.
If you or your child age 3 or older has atopic dermatitis (eczema), you may be able to help our researchers learn why some people with eczema have increased risk of skin infection.
Do you have eczema? If you are age 18 to 60, you may qualify for an NIH sponsored clinical trial to see if an investigational lotion is safe and if the lotion reduces or even eliminates, bacteria that cause skin infections. Compensation provided for qualified participants.
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.
National Jewish Health researchers are studying a new phosphate cream that could reduce painful inflammation. Children ages 2 to 17 with atopic dermatitis may qualify. Learn more.
The purpose of this research study is to determine if an investigational medication can reduce inflammation, tissue scarring, and the number of pulmonary exacerbations, or episodes when breathing is more difficult, in people with cystic fibrosis (CF).
The purpose of this study is to determine how two medications, azithromycin and inhaled tobramycin, work when taken together to treat cystic fibrosis (CF) patients with chronic pseudomonas aeruginosa (PA) lung infections.
Our researchers are studying an investigational combination of medications, one used to treat asthma in adults and the other not yet approved to treat adult asthma, to determine if it can improve symptoms and lung function in asthma patients age 5 to 17.
Our researchers are studying an investigational medication to determine if it improves lung function in teens with asthma. By blocking a key receptor that causes inflammation in the lungs, the medication may improve and prevent symptoms such as wheezing and shortness of breath.
Are you pregnant? Do you have a family history of allergic disease (asthma, eczema, environmental allergies, hay fever, etc.)? You may be able to help our researchers determine if your child and others are at risk of developing eczema and food allergies.
-
Gender: Any Gender
-
Ages: Parents 18-50, newborns 3-6 months
-
Compensation: Not Provided
-
Time Required: Four 1-hour visits over 6 months
How does inflammation differ in psoriasis and atopic dermatitis (eczema) patients? Our researchers are trying to find out. If you or your child (age 12 or older) has a history of psoriasis, we need your help for a clinical trial.
If you or your child age 3 or older has atopic dermatitis (eczema), you may be able to help our researchers learn why some people with eczema have increased risk of skin infection.